European Surgical Research

Original Paper

Sex Hormone Changes in Morbidly Obese Patients after Vertical Banded Gastroplasty

Bastounis E.A.a · Karayiannakis A.J.a · Syrigos K.b · Zbar A.c · Makri G.G.a · Alexiou D.a

Author affiliations

a First Department of Surgery, and b Endocrinology Unit, First Department of Internal Medicine, University of Athens, Laikon Hospital, Athens, Greece; c Department of Surgery, Royal Postgraduate Medical School, London, UK

Related Articles for ""

Eur Surg Res 1998;30:43–47

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Published online: January 21, 1998
Issue release date: January – February

Number of Print Pages: 5
Number of Figures: 0
Number of Tables: 3

ISSN: 0014-312X (Print)
eISSN: 1421-9921 (Online)

For additional information: https://www.karger.com/ESR

Abstract

Serum sex hormone levels were measured preoperatively in 57 morbidly obese patients (19 men and 38 premenopausal women) and 12 months after vertical banded gastroplasty. In the male group, there was a significant decrease in estradiol and an increase in follicle-stimulating hormone (FSH), total testosterone and sex-hormone-binding globulin (SHBG). Among female patients, a significant decrease in estradiol, total and free testosterone and an increase in FSH and SHBG was found. Irregular menses present preoperatively in 5 women were corrected after successful weight loss. In conclusion, altered sex hormonal levels and gynecologic abnormalities associated with morbid obesity are corrected with adequate weight loss following vertical banded gastroplasty.




Related Articles:


References

  1. Samojlik E, Kirschner MA, Silber D, Schneider G, Ertel NH: Elevated production and metabolic clearance rates of androgens in morbidly obese women. J Clin Endocrinol Metab 1984;59:949–954.
  2. Kirschner MA, Samojlik E, Drejka M, Szmal E, Schneider G, Ertel NH: Androgen-estrogen metabolism in women with upper body versus lower body obesity. J Clin Endocrinol Metab 1990;70:473–479.
  3. Bernasconi D, Del Monte P, Meozzi M, Randazzo M, Marugo A, Badaracco B, Marugo M: The impact of obesity on hormonal parameters in hirsute and nonhirsute women. Metabolism 1996;45:72–75.
  4. Grenman S, Rönnemaa T, Irjala K, Kaihola HL, Grönroos M: Sex steroid, gonadotropin, cortisol and prolactin levels in healthy, massively obese women: Correlation with abdominal fat cell size and effect of weight reduction. J Clin Endocrinol Metab 1986;63:1257–1261.
  5. Pasquali R, Antenucci D, Casimirri F, Venturoli S, Paradisi R, Fabbri R, Balestra V, Melchionda N, Barbara L: Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss. J Clin Endocrinol Metab 1989;68:173–179.
  6. Möller H, Mellemgaard A, Lindvig K, Olsen JH: Obesity and cancer risk: A Danish record linkage study. Eur J Cancer 1994;30:344–350.
  7. Glass AR, Swerdloff RS, Bray GA, Dahms WT, Atkinson RL: Low serum testosterone and sex-hormone-binding-globulin in massively obese men. J Clin Endocrinol Metab 1977;45:1211–1219.
    External Resources
  8. Strain GW, Zumoff B, Kream J, Strain JJ, Deucher R, Rosenfeld RS, Levin J, Fukushima DK: Mild hypogonadotropic hypogonadism in obese men. Metabolism 1982;31:871–875.
    External Resources
  9. Pasquali R, Casimirri F, Melchionda N, Fabbri R, Capelli M, Plate L, Patrono D, Balestra V, Barbara L: Weight loss and sex steroid metabolism in massively obese man. J Endocrinol Invest 1988;11:205–210.
    External Resources
  10. Stanik S, Dornfeld LP, Maxwell MH, Viosca SP, Korenman SG: The effect of weight loss on reproductive hormones in obese men. J Clin Endocrinol Metab 1981;53:828–832.
    External Resources
  11. Leenen R, Van Der Kooy K, Seidell JC, Deurenberg P, Koppeschaar HPF: Visceral fat accumulation in relation to sex hormones in obese men and women undergoing weight loss therapy. J Clin Endocrinol Metab 1994;78:1515–1520.
  12. Ferriman D, Gallwey JD: Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961;21:1440–1447.
  13. Mason EE: Vertical banded gastroplasty for obesity. Arch Surg 1982;117:701–706.
  14. Nestler JE, Strauss JF: Insulin as an effector of human ovarian and adrenal steroid metabolism. Endocrinol Metab Clin North Am 1991;20:807–823.
  15. Schneider G, Kirschner MA, Berkowitz R, Ertel NH: Increased estrogen production in obese men. J Clin Endocrinol Metab 1979;48:633–638.
  16. Deslypere JP, Verdonck L, Vermeulen A: Fat tissue: A steroid reservoir and site of steroid metabolism. J Clin Endocrinol Metab 1985;61:564–570.
  17. Kurtz BR, Givens JR, Komindr S, Stevens MD, Karas JG, Bittle JB, Judge D, Kitabchi AE: Maintenance of normal circulating levels of Δ4-androstenedione and dehydroepiandrosterone in simple obesity despite increased metabolic clearance rates: Evidence for a servo-control mechanism. J Clin Endocrinol Metab 1987;64:1261–1267.
  18. Poretsky L, Piper B: Insulin resistance, hypersecretion of LH, and a dual-defect hypothesis for the pathogenesis of polycystic ovary syndrome. Obstet Gynecol 1994;84:613–621.
  19. Pasquali R, Casimirri F: The impact of obesity on hyperandrogenism and polycystic ovary syndrome in premenopausal women. Clin Endocrinol (Oxf) 1993;39:1–16.
  20. Nestler JE, Barlascini CO, Matt DW, Steingold KA, Plymate SR, Clore JN, Blackard WG: Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 1989;68:1027–1032.
  21. Plymate SR, Jones RE, Matej LA, Friedl KE: Regulation of sex hormone binding globulin (SHBG) production in Hep G2 cells by insulin. Steroids 1988;52:339–340.
  22. Nestler JE, Powers LP, Matt DW, Steingold KA, Plymate SR, Rittmaster RS, Clore JN, Blackard WG: A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab 1991;72:83–89.
    External Resources
  23. Pasquali R, Casimirri F, De Iasio R, Mesini P, Boschi S, Chierici R, Flamia R, Biscotti M, Vicennati V: Insulin regulates testosterone and sex hormone-binding globulin concentrations in adult normal weight and obese men. J Clin Endocrinol Metab 1995;80:654–658.
  24. Kiddy DS, Hamilton-Fairley D, Bush A, Short F, Anyaoku V, Reed MJ, Franks S: Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol 1992;36:105–111.
  25. Strain GW, Zumoff B, Miller LK, Rosner W, Levit C, Kalin M, Hershcopf RJ, Rosenfeld RS: Effect of massive weight loss on hypothalamic-pituitary-gonadal function in obese men. J Clin Endocrinol Metab 1988;66:1019–1023.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Published online: January 21, 1998
Issue release date: January – February

Number of Print Pages: 5
Number of Figures: 0
Number of Tables: 3

ISSN: 0014-312X (Print)
eISSN: 1421-9921 (Online)

For additional information: https://www.karger.com/ESR


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP